Common Contracts

WAIVER

Waiver • April 3rd, 2018 • Heron Therapeutics, Inc. /De/ • Pharmaceutical preparations • California

• Contract Type
  Waiver
• Filed
  April 3rd, 2018
• Company
  Heron Therapeutics, Inc. /De/
• Industry
  Pharmaceutical preparations
• Jurisdiction
  California

This WAIVER (this “Waiver”) is made and entered into as of March 28, 2018, by and between Tang Capital Partners, LP, a Delaware limited partnership (“TCP”), and Heron Therapeutics, Inc., a Delaware corporation formerly known as A.P. Pharma, Inc. (“Heron”), with respect to the Securities Purchase Agreement, dated April 24, 2011 (the “SPA”), by and among Heron, TCP, Baker Bros. Investments II, L.P., a Delaware limited partnership (“BBI”), Baker Brothers Life Sciences, L.P., a Delaware limited partnership (“BBLS”), and 14159, L.P., a Delaware limited partnership (together with TCP, BBI and BBLS, the “Purchasers”).

WAIVER

Waiver • January 24th, 2017 • Heron Therapeutics, Inc. /De/ • Pharmaceutical preparations • California

• Contract Type
  Waiver
• Filed
  January 24th, 2017
• Company
  Heron Therapeutics, Inc. /De/
• Industry
  Pharmaceutical preparations
• Jurisdiction
  California

This WAIVER (this “Waiver”) is made and entered into as of January 18, 2017, by and between Tang Capital Partners, LP, a Delaware limited partnership (“TCP”), and Heron Therapeutics, Inc., a Delaware corporation formerly known as A.P. Pharma, Inc. (“Heron”), with respect to the Securities Purchase Agreement, dated April 24, 2011 (the “SPA”), by and among Heron, TCP, Baker Bros. Investments II, L.P., a Delaware limited partnership (“BBI”), Baker Brothers Life Sciences, L.P., a Delaware limited partnership (“BBLS”), and 14159, L.P., a Delaware limited partnership (together with TCP, BBI and BBLS, the “Purchasers”).